J2 Capital Management’s GSK GSK Stock Holding History

J2 Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$545K	Sell	11,323 -15	-0.1%	-$766	0.35%	78
2026 Q2	$594K	Sell	11,338 -1,414	-11%	-$74.8K	0.4%	62
2026 Q1	$704K	Sell	12,752 -443	-3%	-$24K	0.48%	46
2025 Q4	$647K	Sell	13,195 -431	-3%	-$20.1K	0.47%	48
2025 Q3	$588K	Sell	13,626 -156	-1%	-$6.09K	0.44%	57
2025 Q2	$529K	Buy	13,782 +99	+0.7%	+$3.78K	0.42%	58
2025 Q1	$530K	Sell	13,683 -3,930	-22%	-$144K	0.49%	36
2024 Q4	$596K	Buy	+17,613	New	+$634K	0.56%	35
2023 Q3	$604K	Buy	16,662 +26	+0.2%	+$923	0.76%	28
2023 Q2	$593K	Buy	16,636 +1,548	+10%	+$55.5K	0.7%	33
2023 Q1	$537K	Buy	15,088 +521	+4%	+$18.2K	0.83%	27
2022 Q4	$512K	Buy	14,567 +558	+4%	+$18.6K	0.88%	22
2022 Q3	$412K	Buy	14,009 +9,251	+194%	+$351K	0.78%	23
2022 Q2	$259K	Sell	4,758 -1,508	-24%	-$83.2K	0.39%	61
2022 Q1	$341K	Sell	6,266 -721	-10%	-$39.2K	0.37%	56
2021 Q4	$385K	Buy	+6,987	New	+$363K	0.37%	44

Other funds holding GSK

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.9B AUM 29.83% 1-Year Est. Return

Miller Howard Investments Kingston, New York $3.72B AUM 18.2% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

J2 Capital Management's GSK Position: Q3 2026 in Review

J2 Capital Management reduced its GSK (GSK) stake by 0.13% in Q3 2026, selling an estimated $766 and leaving 11,323 shares worth $545K. The position accounts for 0.35% of the portfolio, ranked #78.

J2 Capital Management first reported a position in GSK in Q4 2021 and has held it in 16 quarters since. The position peaked at $704K in Q1 2026. 553 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

J2 Capital Management held 11,323 shares of GSK worth $545K as of Q3 2026.
J2 Capital Management sold 15 GSK shares in Q3 2026, an estimated $766.
GSK made up 0.35% of J2 Capital Management's portfolio in Q3 2026, its #78 holding.
J2 Capital Management first reported a position in GSK in Q4 2021 and has held it in 16 quarters since.
J2 Capital Management's GSK position peaked at $704K in Q1 2026.
553 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on J2 Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.